THE ROLE AND IMPACT OF PATHOLOGY REVIEW ON STAGE AND GRADE ASSESSMENT OF STAGES TA AND T1 BLADDER TUMORS: A COMBINED ANALYSIS OF 5 EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER TRIALS-Reference-Cited by-同舟云学术

THE ROLE AND IMPACT OF PATHOLOGY REVIEW ON STAGE AND GRADE ASSESSMENT OF STAGES TA AND T1 BLADDER TUMORS: A COMBINED ANALYSIS OF 5 EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER TRIALS

Published:2000-11 Issue:5 Volume:164 Page:1533-1537
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

VAN DER MEIJDEN A.¹,SYLVESTER R.¹,COLLETTE L.¹,BONO A.¹,TEN KATE F.¹

Affiliation:

1. From the Bosch Medicentrum, ’s Hertogenbosch and Academisch Medisch Centrum, Amsterdam, The Netherlands, European Organization for Research and Treatment of Cancer Data Center, Brussels, Belgium, and Ospedale di Circolo e Fundazione Macchi, Varese, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer;Pawinski;J Urol,1996

2. Prognostic factors in superficial bladder cancer;Aso,1986

3. Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. II. Prognostic Importance;Carbin;J Urol,1991

4. Bladder tumors. Treated natural history;Wolf,1993

5. Prognostic factors in Ta, T1 (superficial) bladder cancer;Aso,1993

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second opinions and pathological review impact the clinical management of patients with muscle-invasive bladder cancer;2024-09-03

2. Central pathology review and its prognostic value in upper tract urothelial carcinoma patients: a nationwide multi-institutional study;Scientific Reports;2024-08-23

3. Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection;European Urology;2024-08

4. The Impact of Second Opinion Expert Pathology Review in Patient Management at the Time of Transurethral Resection of the Bladder;European Urology Focus;2024-06

5. Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non–muscle-invasive Spectrum;European Urology Oncology;2023-04